8 years ago The UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim, Imperial Innovations and Oxford BioMedica Announce New Partnership to Develop First-In-Class Gene Therapy for Cystic Fibrosis
8 years ago Flutterby Fundraisers to Sponsor Consortium Scientist
8 years ago New Publication - Gelinas et al 2017 - Media Supplements to Improve Lentiviral Vector Production Yields
9 years ago Gene Therapy Funding Update
9 years ago Consortium Student Live Facebook Interview from ASGCT
9 years ago
EIT Health Transition Fellowship for Consortium Student
Monday, October 3rd 2016
Consortium PhD Student and Clarendon Fund Scholar, Jean-Francois Gélinas (Keble College, Oxford) has secured an EIT Health Transition Fellowship.
The scheme focuses on providing funding to close the gap between completion of a doctoral thesis and obtaining seed funding for innovative idea based on DPhil research.
Jean-Francois, a DPhil student with Prof Deborah Gill and Prof Steve Hyde in Oxford, has secured a Gold Award worth €27,500 to further his research on enhancing lentiviral vector production for gene therapy.
He has also been invited to Barcelona to pitch his innovation to EIT Health partners. JF recently submited his D.Phil thesis and will defend his work later this month in his viva.
Jean-Francois always carries a copy of his D.Phil Thesis
Presentation of Multi Dose Clinical Trial Results (2015): Prof Eric Alton presents the data from our MD clinical trial to an invited audience from the UK CF community. May 30 2015, Imperial College, London. More...
